ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
Go back to ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing| Abbott Laboratories (NYSE: ABT) | Delayed: 105.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $105.52 | 52 Week High | $46.38 | |||
| Open | $105.52 | 52 Week Low | $36.00 | |||
| Day High | $105.52 | P/E | 70.35 | |||
| Day Low | $105.52 | EPS | $1.50 | |||
| Volume | 2,674 | |||||
